Skip to content

Clinical trials

Phase 2 Liver Cirrhosis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Phase: Phase 2 Country / region: Italy Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20101
20122
20131
20151
20171
20181
20211
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated4
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Gilead Sciences3
Sanofi3
Axcella Health, Inc1
Azienda Ospedaliera di Padova1
European Foundation for Study of Chronic Liver Failure1
Galmed Research and Development, Ltd.1
Novartis Pharmaceuticals1
Tobira Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis15
Non-alcoholic Fatty Liver Disease7
Liver Diseases4
Ascites3
Fibrosis3
Fatty Liver2
Acute-On-Chronic Liver Failure1
Cholangitis, Sclerosing1
Diabetes Mellitus1
End Stage Liver Disease1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.